摘要
药物反应中出现类似过敏症状的,有证据表明是由药物特异性抗体或T细胞引起的反应,我们称之为药物过敏反应。为了提供足够的治疗方案和合适的预防措施,应该对此过敏反应有明确的诊断。近来由欧洲变应性反应与临床免疫学会(EAACI)成立的iCAALL、美国过敏、哮喘、免疫学会(AAAI),美国过敏、哮喘与免疫学院(ACAAI)以及世界过敏组织(WAO)已经决定推动药物过敏的国际共识。此草案的目的是强调已有指南中共同的重要信息,同时更重要的是回顾和探讨其中的不同之处,为其更广泛的传播提供了更多的参考。
When drug reactions resembling allergy occur, they are called drug allergy reactions before showing the evidence of either drug-specific antibodies or T cells. A definitive diagnosis of such reaction is required in order to institute adequate treatment options and proper preventive measures. The International Collaboration in Asthma, Allergy and Immunology （iCAALL）, recently formed by the European Academy of Allergy and Clinical Immunology （EAACI）, the American Academy of Allergy, Asthma and Immunology （AAAAI）, the American College of Allergy, Asthma and Immunology （ACAAI）, and the World Allergy Organization （WAO）, has decided to proceed with the compilation of an International consensus （ICON） on drug allergy. The purpose of this document is to highlight the key messages that are common to the existing guidelines, while critically reviewing and commenting on any differences, thus providing a comprehensive reference to be disseminated more widely.
出处
《医学与哲学（B）》
2015年第7期31-34,56,共5页
Medicine & Philosophy(B)
关键词
药物过敏
药物超敏反应
国际共识
drug allergy, drug hypersensitivity reaction, international consensus
